← Back to Search

Genomic/Transcriptomic Analysis for Lymphoma

N/A
Recruiting
Led By Jason Westin, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a commercial test to see if it helps guide care for people with lymphoma.

Who is the study for?
This trial is for adults over 18 with a confirmed diagnosis of diffuse large B-cell lymphoma that needs treatment. Participants must provide written consent to be part of the study.
What is being tested?
The trial is examining the effectiveness of using a commercial test called Molecular Functional Portrait by BostonGene to guide treatment decisions in patients with lymphoma.
What are the potential side effects?
Since this trial involves molecular testing and not drug intervention, there are no direct side effects from treatments like you would expect with medication or therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Molecular TestingExperimental Treatment1 Intervention
Molecular Functional (MF) Portrait (a commercial test conducted by the sponsor of this study, BostonGene) in guiding lymphoma care.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,069 Previous Clinical Trials
1,802,575 Total Patients Enrolled
260 Trials studying Lymphoma
32,526 Patients Enrolled for Lymphoma
Jason Westin, MDPrincipal InvestigatorM.D. Anderson Cancer Center
3 Previous Clinical Trials
118 Total Patients Enrolled
3 Trials studying Lymphoma
118 Patients Enrolled for Lymphoma

Media Library

Molecular Testing Clinical Trial Eligibility Overview. Trial Name: NCT05464823 — N/A
Lymphoma Research Study Groups: Molecular Testing
Lymphoma Clinical Trial 2023: Molecular Testing Highlights & Side Effects. Trial Name: NCT05464823 — N/A
Molecular Testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05464823 — N/A
~40 spots leftby May 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top